KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Receivables - Other (2020 - 2023)

Historic Receivables - Other for Organon (OGN) over the last 4 years, with Q1 2023 value amounting to $344.0 million.

  • Organon's Receivables - Other fell 391.06% to $344.0 million in Q1 2023 from the same period last year, while for Mar 2023 it was $344.0 million, marking a year-over-year decrease of 391.06%. This contributed to the annual value of $374.0 million for FY2022, which is 719.6% down from last year.
  • Per Organon's latest filing, its Receivables - Other stood at $344.0 million for Q1 2023, which was down 391.06% from $374.0 million recorded in Q4 2022.
  • Organon's 5-year Receivables - Other high stood at $991.0 million for Q2 2021, and its period low was $189.0 million during Q4 2020.
  • In the last 4 years, Organon's Receivables - Other had a median value of $403.0 million in 2021 and averaged $491.0 million.
  • In the last 5 years, Organon's Receivables - Other soared by 11322.75% in 2021 and then tumbled by 5620.59% in 2022.
  • Organon's Receivables - Other (Quarter) stood at $189.0 million in 2020, then skyrocketed by 113.23% to $403.0 million in 2021, then dropped by 7.2% to $374.0 million in 2022, then fell by 8.02% to $344.0 million in 2023.
  • Its Receivables - Other was $344.0 million in Q1 2023, compared to $374.0 million in Q4 2022 and $412.0 million in Q3 2022.